annual cash & cash equivalents:
$76.25M-$11.96M(-13.56%)Summary
- As of today (June 1, 2025), AGIO annual cash & cash equivalents is $76.25 million, with the most recent change of -$11.96 million (-13.56%) on December 31, 2024.
- During the last 3 years, AGIO annual cash & cash equivalents has fallen by -$126.88 million (-62.46%).
- AGIO annual cash & cash equivalents is now -62.46% below its all-time high of $203.13 million, reached on December 31, 2021.
Performance
AGIO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$78.96M+$2.72M(+3.56%)Summary
- As of today (June 1, 2025), AGIO quarterly cash & cash equivalents is $78.96 million, with the most recent change of +$2.72 million (+3.56%) on March 31, 2025.
- Over the past year, AGIO quarterly cash & cash equivalents has dropped by -$39.80 million (-33.51%).
- AGIO quarterly cash & cash equivalents is now -95.82% below its all-time high of $1.89 billion, reached on March 31, 2021.
Performance
AGIO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AGIO Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.6% | -33.5% |
| 3 y3 years | -62.5% | -1.3% |
| 5 y5 years | -5.8% | -11.4% |
AGIO Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.5% | at low | -68.9% | +22.7% |
| 5 y | 5-year | -62.5% | at low | -95.8% | +22.7% |
| alltime | all time | -62.5% | +443.4% | -95.8% | +462.8% |
AGIO Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $78.96M(+3.6%) |
| Dec 2024 | $76.25M(-13.6%) | $76.25M(-69.9%) |
| Sep 2024 | - | $253.73M(+200.2%) |
| Jun 2024 | - | $84.52M(-28.8%) |
| Mar 2024 | - | $118.76M(+34.6%) |
| Dec 2023 | $88.20M(-36.7%) | $88.20M(+37.1%) |
| Sep 2023 | - | $64.33M(-24.1%) |
| Jun 2023 | - | $84.75M(-18.6%) |
| Mar 2023 | - | $104.14M(-25.2%) |
| Dec 2022 | $139.26M(-31.4%) | $139.26M(+13.7%) |
| Sep 2022 | - | $122.45M(+38.3%) |
| Jun 2022 | - | $88.54M(+10.6%) |
| Mar 2022 | - | $80.03M(-60.6%) |
| Dec 2021 | $203.13M(+59.4%) | $203.13M(-49.2%) |
| Sep 2021 | - | $400.22M(-58.7%) |
| Jun 2021 | - | $969.12M(-48.7%) |
| Mar 2021 | - | $1.89B(+1381.5%) |
| Dec 2020 | $127.44M(+57.5%) | $127.44M(+21.5%) |
| Sep 2020 | - | $104.86M(-64.6%) |
| Jun 2020 | - | $295.86M(+232.1%) |
| Mar 2020 | - | $89.09M(+10.1%) |
| Dec 2019 | $80.93M(+14.8%) | $80.93M(-1.0%) |
| Sep 2019 | - | $81.71M(-2.2%) |
| Jun 2019 | - | $83.58M(-19.2%) |
| Mar 2019 | - | $103.44M(+46.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $70.50M(-31.4%) | $70.50M(-54.9%) |
| Sep 2018 | - | $156.48M(-25.6%) |
| Jun 2018 | - | $210.32M(-42.3%) |
| Mar 2018 | - | $364.47M(+254.8%) |
| Dec 2017 | $102.72M(-36.1%) | $102.72M(-22.6%) |
| Sep 2017 | - | $132.74M(-4.3%) |
| Jun 2017 | - | $138.72M(-30.7%) |
| Mar 2017 | - | $200.28M(+24.6%) |
| Dec 2016 | $160.75M(+124.0%) | $160.75M(-43.7%) |
| Sep 2016 | - | $285.50M(+22.0%) |
| Jun 2016 | - | $234.05M(+499.6%) |
| Mar 2016 | - | $39.03M(-45.6%) |
| Dec 2015 | $71.76M(+411.5%) | $71.76M(-10.3%) |
| Sep 2015 | - | $80.05M(+10.4%) |
| Jun 2015 | - | $72.53M(+105.7%) |
| Mar 2015 | - | $35.26M(+151.3%) |
| Dec 2014 | $14.03M(-80.4%) | $14.03M(-80.0%) |
| Sep 2014 | - | $70.05M(-35.3%) |
| Jun 2014 | - | $108.25M(+229.6%) |
| Mar 2014 | - | $32.84M(-54.1%) |
| Dec 2013 | $71.56M(-21.6%) | $71.56M(-32.5%) |
| Sep 2013 | - | $106.01M(+36.8%) |
| Jun 2013 | - | $77.48M(-7.1%) |
| Mar 2013 | - | $83.38M(-8.7%) |
| Dec 2012 | $91.30M(-22.4%) | $91.30M |
| Dec 2011 | $117.66M | - |
FAQ
- What is Agios Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Agios Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Agios Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of AGIO is $76.25M
What is the all time high annual cash & cash equivalents for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual cash & cash equivalents is $203.13M
What is Agios Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, AGIO annual cash & cash equivalents has changed by -$11.96M (-13.56%)
What is Agios Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AGIO is $78.96M
What is the all time high quarterly cash & cash equivalents for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly cash & cash equivalents is $1.89B
What is Agios Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, AGIO quarterly cash & cash equivalents has changed by -$39.80M (-33.51%)